Database Member Home
RAS Member Home
Regulatory restrictions and growing competition have made it increasingly important for biopharmaceutical organizations to develop a tactical approach to Key Opinion Leader (KOL) engagement. Identifying what Key Opinion Leaders value in their relationship and evaluating key KOL activities will help organizations in their KOL management efforts.
This video outlines the top things thought leaders seem to value most in their relationship with organizations and tactics that help build robust Key Opinion Leader relationships. It also provides strategic inputs on the involvement and role of Medical Science Liaisons (MSLs) in Thought Leader Management.
The study benchmarks the organizational structures, management strategies, activities, tools and tactics associated with excellence in KOL management. MA leaders will gain an understanding of approaches to KOL management at leading companies.
Pharmaceutical companies continue to improve the effectiveness of their managed care interactions by employing specialized medical liaisons who can speak the "payer language... (ID POP-283)
Read More »
In pharma, regulatory and access restrictions have reshaped key interactions with thought leaders... (ID POP-267)
Key Opinion Leaders (KOLs) are recognized as one of the most effective avenues for building awareness in medical and scientific communities... (ID POP-253)
Pharmaceutical and life science companies rely heavily on key opinion leaders (KOLs) to improve their credibility in the marketplace... (ID PSM-235)
Pharmaceutical and medical device organizations seek strategic insights and guidance to successfully navigate the complexities of the changing healthcare landscape... (ID PSM-319)
As Medical Science Liaisons (MSLs) increasingly face restricted access to physicians and KOLs, it is important for biopharmaceutical and medical device companies to empower MSLs with new processes and tools that facilitate rapid and effective customer engagement... (ID POP-286)
The growing demand for scientific and medical data in the biopharmaceutical industry has pushed organizations to develop effective KOL engagement strategies for their field-based medical and field-based outcomes and pricing group... (ID POP-288)